Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970 million ...

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...

New Mountain Capital, LLC ("New Mountain"), a leading growth-oriented investment firm with more than $55 billion in assets under management, today announced a definitive agreement to acquire Machinify ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Lung cancer remains one of the deadliest cancers globally. Non-small cell lung cancer (NSCLC), which accounts for 85% of all lung cancer cases, is particularly challenging to treat due to difficulties ...